Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
BrightSpire's commercial real estate loan book is beginning to show the earnings power investors have been waiting for. The stock yields north of 12% and trades below book, while recent cash flow and falling short interest suggest a window for a mid-term long trade. This idea lays out an entry at $4.95, a stop at $4.30 and a target of $6.15 over a …
Brazil's Progressives Party announced it will remain neutral in the October presidential election, a move that, if maintained, prevents Senator Tereza Cristina from joining Senator Flavio Bolsonaro's ticket despite his earlier statement that she had accepted his invitation. Cristina's backing among rural voters and the agribusiness caucus had been …
Norway's main index closed modestly higher on Friday, lifted by gains in Healthcare Equipment & Services, Pharma Biotech & Life Sciences and Utilities. The Oslo OBX rose 0.05% as top performers included Subsea 7, Frontline and CMB.Tech, while SalMar, Mowi and Yara were among the laggards. Oil futures firmed and gold futures declined; the krone stre…
Israel's benchmark TA 35 index finished higher after the close on Friday, led by gains in the Biomed, Insurance and Technology sectors. Market breadth was positive, with substantially more advancing issues than decliners. Commodity and currency markets showed mixed moves, with crude and Brent rising while gold futures fell.
Tyler Technologies stock fell in morning trading after a second-quarter earnings release that narrowly beat on adjusted EPS but missed revenue and adjusted EBITDA estimates. Analyst price target reductions and the market's reaction to profitability metrics extended selling pressure even as the company reported strong SaaS growth, record bookings an…
Greece's main stock index closed marginally lower on Friday, with losses concentrated in the Telecoms, Household and Basic Resources sectors. The Athens General Composite fell 0.08% as a narrow plurality of stocks advanced while several mid- and small-cap names posted notable moves. Commodity markets registered mixed action, with gold down and crud…
Options pricing indicates Oklo Inc. shares could swing about 13% when the company reports earnings on Aug. 7 before the market opens, according to options data compiled by Bloomberg. Over the last eight earnings announcements, the stock's actual moves have both exceeded and fallen short of the options-implied magnitudes, producing a mixed record.
Tyler Technologies shares fell after several sell-side analysts reduced their price targets on the stock. The downgrades come alongside Tyler's purchase of CODY Systems, a public safety software provider. Mixed second-quarter fiscal 2026 results cited by analysts contributed to the negative market reaction.
Options-market pricing indicates Wendy’s Co. (WEN) shares could move about 7.8% when the company releases quarterly results on Aug. 7 before the opening bell. Historical reactions to prior earnings have varied widely, with actual moves both falling short of and exceeding options-implied expectations.
Options pricing ahead of Calumet Inc.'s scheduled earnings release on August 7 implies roughly a 7% price swing. A review of eight prior post-earnings sessions shows mixed outcomes - with the firm recording several instances where the stock moved by more than what option-implied expectations predicted.
Options market pricing implies a 7.1% share-price move for Under Armour Inc. Class A (NYSE: UAA) when the company releases earnings on August 7 before the open, according to Bloomberg options data. The stock has historically moved more than the options-implied range in six of its last eight earnings reports.
Activist investor Jana Partners says Alkami Technology is failing to run an adequate sale process, according to a letter delivered to the company's board. Jana reports potential buyers told the firm that prior interest was stymied by limited engagement from Alkami and what buyers viewed as unrealistic price expectations. The activist, which holds m…
T3 Defense Inc., a Nasdaq-listed defense technology holding company, announced strong year-to-date operational results from its subsidiaries Rimon and Tiltan. Both subsidiaries achieved record revenue, backlog, and new orders in July 2026, with Rimon exceeding its full-year 2025 revenue in just seven months and anticipating further growth for the y…
Friday's trading session produced marked intraday volatility across market-cap ranges, with mega-cap Apple among notable decliners and a mix of large-, mid- and small-cap names swinging sharply higher or lower. Several companies reported earnings or guidance that coincided with steep share moves, while analyst actions and other company-specific cat…
Everus Construction Group said it has signed a definitive agreement to acquire Epsilon Industries for $295 million in cash, an acquisition to be financed with existing cash and borrowings. The transaction, which prompted a 3.9% rise in Everus shares, is slated to close in the third quarter of 2026 pending regulatory approvals and customary closing …
A Government Accountability Office report finds the U.S. Air Force's $21 billion program to modernize B-52 bombers - managed by Boeing - is encountering cost increases, schedule slippages and performance shortfalls across the majority of its upgrade efforts. The F130-200 engine program from Rolls-Royce has seen the largest cost rise and notable sch…
Perella Weinberg Partners shares jumped 19.3% in morning trading after the advisory firm posted adjusted EPS of $0.20, about double consensus expectations of roughly $0.10, and reported $157 million in revenue. The beat was amplified by depressed sentiment heading into the release, including a fresh 52-week low and steep cuts to EPS forecasts. The …
Vertiv's Q2 revenue miss has rattled the stock, but the company's core exposure to AI data center power and cooling plus strong cash generation make this a compelling trade. We upgrade to long and lay out a clear entry at $240.20, a $360 target and a $210 stop for a long-term (180 trading days) tactical position.
MongoDB's stock has pulled back from its 52-week highs, but the business metrics that matter - Atlas growth, positive free cash flow of $591M and improving technicals - point to a mid-term buying opportunity. This trade idea outlines an entry at $328.00, a $400 target and a $300 stop, with a primary horizon of 45 trading days and clear catalysts an…
Banco Santander Brasil's ADR leapt 12.5% in morning trading to $5.68, reversing much of a sharp selloff that followed disappointing Q2 2026 results and a downgrade from JPMorgan. The bank reported recurring net income of BRL 3 billion and a 12.5% return on average equity, while acknowledging higher credit costs and a deliberate move to a more conse…
BioAge Labs stock plunged roughly 60% following Novo Nordisk’s announcement that its Phase 3 ZEUS study of ziltivekimab did not reduce the risk of major adverse cardiovascular events versus placebo in more than 6,300 patients. The outcome, which produced a hazard ratio of 0.99, hit investor confidence in inflammation-targeting cardiovascular therap…
Citi told clients that capital flows into South Korea's Kospi show clear buy-on-dip behavior, citing a record single-day foreign net purchase, a sharp moderation in monthly foreign net selling, accelerated passive inflows, tighter retail rules for leveraged ETFs, and renewed pension buying. The bank maintained a Kospi target of 10,000 and flagged p…
Karyopharm Therapeutics shares plunged in morning trading after its Phase 3 XPORT-EC-042 trial of selinexor in TP53 wild-type advanced or recurrent endometrial cancer failed to meet the primary endpoint for progression-free survival. The miss led management to scale back investment in the endometrial program and analysts to sharply lower ratings an…
DexCom shares jumped sharply after the company reported second-quarter 2026 results that exceeded consensus across key metrics. Strong revenue and adjusted EPS, improved gross margins tied to manufacturing gains and product rollout, updated full-year guidance, sizable free cash flow and a large share-repurchase program combined with analyst target …
Moleculin Biotech, a Nasdaq-listed clinical-stage pharmaceutical company, announced the pricing of a $9.3 million public offering consisting of common stock and warrants. The proceeds will fund further clinical development of its lead drug candidate Annamycin, targeting relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung meta…
